Frontline therapy for DLBCL is evolving with the integration of targeted and cellular therapies, demonstrating promising outcomes.
Sara B. Leidy, PharmD, BCOP
Advertisement
Articles by Sara B. Leidy, PharmD, BCOP
Advertisement
Latest Updated Articles
Evolving Frontline Treatment Strategies in Diffuse Large B-Cell LymphomaFebruary 20th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
2
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
3
Isatuximab Wins FDA Approval, Becoming Second Subcutaneous Anti-CD38 for Multiple Myeloma
4
FDA Expands Wilate Approval for Routine Prophylaxis in Children Younger Than 6 With von Willebrand Disease
5